Tools

Determining the structure of unknown natural compounds is a slow and expensive part of drug screening and development – but… »   

The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and… »   

Use of MC-1 (a naturally occurring metabolite of vitamin B6) before and for 30 days after coronary artery bypass graft… »   

As the commonly used blood thinner heparin is recalled around the world and some doctors worry about shortages, researchers say… »   

A six-year study pitting the newer blood pressure drug Micardis with the ACE inhibitor ramipril found Micardis was just as… »   

Merck & Co said on Monday that patients on its experimental obesity drug lost more than twice as much weight… »   

New data about the controversial cholesterol fighter Vytorin failed to quell concerns that the drug might not be as good… »   

New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes,… »   

New study shows that the use of powerful anticoagulants to prevent pulmonary embolism may actually lead to more deaths after… »   

A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens… »